Patient Engagement for Medtech Companies is Hard: Here’s Some Advice on How to Do it Right

Interview with Neal Sofia

Engaging with patients in a genuine and transparent way is tough.  Really tough.  It’s challenging for all healthcare stakeholders – payers, providers, and industry.

From a medtech perspective, we often times get stuck in a certain mindset when trying to engage with patients. Whether it’s a continuous glucose monitor for diabetic patients or a new hip implant for orthopedic patients, we gravitate towards communicating the features and benefits of our particular product.  For example, this might sounds familiar – “Joe Patient, you should consider our knee implant because it has a greater arc than Competitor X.”

But is this really the right approach?  If our end-goal is for a patient to take action, is this the best way to engage with them?  To answer this question, I invited Neal Sofian to the program.  He’s currently the VP of Engagement & Innovation at Vivacity, a subsidiary of Premera Blue Cross.  Neal is recognized internationally for his work in population health management and behavioral change.

Interview Highlights with Neal Sofian

  • What does patient personalization really mean?  And why messaging around life and context is so important.
  • Why do so many life science companies fail to effectively personalize their messages to patients?
  • What technologies can actually support effective patient engagement?
  • Examples of companies that have been successful at patient personalization.
  • How to overcome some of the legal challenges associated with patient engagement.
  • The top 2 things that medtech or biotech companies should do right now to improve their patient engagement initiatives.
  • Neal’s favorite non-fiction business book, the business leaders he admires the most, and the one piece of advice he’d give to his 30-yr. old self.
Guest
Neal Sofian
VP at Vivacity

Neal Sofian is recognized internationally for over 35 years of innovation in population and corporate health management as well as organizational change.  He is responsible for commercializing the first telephonic coaching programs including Free & Clear and many of the early social networking platforms including the Cancer Society’s ‘Cancer Survivors Network’.  Neal is currently the VP of Engagement & Innovation at Vivacity, a subsidiary of Premera Blue Cross.  He develops new strategies to actively engage the 2 million members of Premera in their health and wellbeing.  He is also a clay artist and has done standup comedy.  Neal holds a master’s degree in public health from the University Of Missouri School Of Medicine.

Download a copy of the interview transcript right here.
Share:
Twitter
Facebook
LinkedIn
Email

Engaging with patients in a genuine and transparent way is tough.  Really tough.  It’s challenging for all healthcare stakeholders – payers, providers, and industry.

From a medtech perspective, we often times get stuck in a certain mindset when trying to engage with patients. Whether it’s a continuous glucose monitor for diabetic patients or a new hip implant for orthopedic patients, we gravitate towards communicating the features and benefits of our particular product.  For example, this might sounds familiar – “Joe Patient, you should consider our knee implant because it has a greater arc than Competitor X.”

But is this really the right approach?  If our end-goal is for a patient to take action, is this the best way to engage with them?  To answer this question, I invited Neal Sofian to the program.  He’s currently the VP of Engagement & Innovation at Vivacity, a subsidiary of Premera Blue Cross.  Neal is recognized internationally for his work in population health management and behavioral change.

Interview Highlights with Neal Sofian

  • What does patient personalization really mean?  And why messaging around life and context is so important.
  • Why do so many life science companies fail to effectively personalize their messages to patients?
  • What technologies can actually support effective patient engagement?
  • Examples of companies that have been successful at patient personalization.
  • How to overcome some of the legal challenges associated with patient engagement.
  • The top 2 things that medtech or biotech companies should do right now to improve their patient engagement initiatives.
  • Neal’s favorite non-fiction business book, the business leaders he admires the most, and the one piece of advice he’d give to his 30-yr. old self.
Guest
Neal Sofian
VP at Vivacity

Neal Sofian is recognized internationally for over 35 years of innovation in population and corporate health management as well as organizational change.  He is responsible for commercializing the first telephonic coaching programs including Free & Clear and many of the early social networking platforms including the Cancer Society’s ‘Cancer Survivors Network’.  Neal is currently the VP of Engagement & Innovation at Vivacity, a subsidiary of Premera Blue Cross.  He develops new strategies to actively engage the 2 million members of Premera in their health and wellbeing.  He is also a clay artist and has done standup comedy.  Neal holds a master’s degree in public health from the University Of Missouri School Of Medicine.

Download a copy of the interview transcript right here.
Share:
Twitter
Facebook
LinkedIn
Email

You May Like These Articles

Premium

Collaborating for Clinical Credibility

Interview with Strados Labs CEO Nick Delmonico

In this interview Nick Delmonico, the CEO of Strados Labs, a company developing a wearable stethoscope to remotely capture lung sounds, discusses how Strados validated its technology through others' research and how starting with a clear understanding of the problem, rather than jumping straight to offering solutions, created significant opportunities for his company. Nick also emphasizes why interpersonal skills and active listening are crucial to success in medtech, and shares strategies for non-dilutive funding as a way to alleviate initial capital constraints while building credibility at the same time.

Premium

Consumer-Facing Medtech

Interview with AliveCor Founder and Chief Medical Officer Dr. David Albert

Dr. David Albert is a man of many talents, blending medical expertise with entrepreneurial zeal. His company, AliveCor, is pioneering the standard for personal ECG devices that extend beyond just hardware, enveloping services and partnerships to offer comprehensive personal cardiovascular solutions. In a freewheeling conversation with Dr. Albert, we take a tour down the lanes of innovation, prototyping, fundraising, and why sometimes you have to ditch the white coat to take your ideas from the lab to the real world.

Premium

Medsider Mentors

Volume VI

In Medsider Mentors Volume VI, we’ve distilled key insights from founders and CEOs of some of the hottest medical device and health technology startups including LimFlow, Field Medical, Sinaptica, Spark Biomedical, InterShunt and many more.

View More Interviews
See the Playbooks

Join Medsider as a Free Subscriber

Subscribe to Medsider and get access to exclusive benefits for free. No spam, 100% privacy, and your email won’t be shared.